Related Experiment Video
Updated: Apr 10, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Innate and Adaptive Immunity in Calcific Aortic Valve Disease
Patrick Mathieu1, Rihab Bouchareb1, Marie-Chloé Boulanger1
1Laboratoire d'Études Moléculaires des Valvulopathies (LEMV), Groupe de Recherche en Valvulopathies (GRV), Quebec Heart and Lung Institute/Research Center, Department of Surgery, Laval University, QC, Canada ; Institut de Cardiologie et de Pneumologie de Québec, 2725 Chemin Sainte-Foy, Québec, QC, Canada G1V 4G5.
Calcific aortic valve disease (CAVD) involves complex immune system interactions. Both innate and adaptive immunity contribute to the mineralization of aortic valves, highlighting new therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Immunology
- Translational Medicine
Background:
- Calcific aortic valve disease (CAVD) is the most common heart valve disorder, characterized by pathological mineralization of aortic valve leaflets.
- Ectopic mineralization in CAVD is intricately linked with both innate and adaptive immune responses.
- Fibrocalcific remodeling in CAVD is associated with activation of the NF-κB pathway.
Purpose of the Study:
- To review the intricate relationship between immune responses and the development of CAVD.
- To provide a translational perspective on the role of immunity in CAVD pathogenesis.
- To highlight the involvement of specific immune pathways and cellular components in CAVD.
Main Methods:
- Review of existing scientific literature on CAVD and immune system interactions.
- Analysis of studies investigating the roles of innate and adaptive immunity in CAVD.
- Examination of molecular pathways such as NF-κB and inflammatory mediators like TNF-α and IL-6.
Main Results:
- Increased expression of TNF-α and IL-6 in mineralized aortic valves promotes an osteogenic program.
- Activation of the innate immune response via Toll-like receptors by factors like oxidized lipids.
- Valve interstitial cells (VICs) produce leukotrienes, potentially amplifying inflammation.
- Evidence suggests an adaptive immune response is triggered during CAVD progression.
Conclusions:
- Immune system activation, involving both innate and adaptive mechanisms, is a key driver of CAVD.
- Specific inflammatory pathways and mediators play critical roles in valve mineralization.
- Understanding these immune links offers potential for novel translational therapeutic strategies for CAVD.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

